Dr. Henry Miller Explains COVID-19 Vaccine Patent Rights

Dr. Henry Miller Explains COVID-19 Vaccine Patent Rights

Dr. Henry Miller talks about the unintended and negative consequences of the Biden administration invalidating patents for COVID=19 vaccines. Dr. Miller explains that while removing patent rights will enable other companies and institutions to produce these vaccines, Biden and the U.S. should have focused on increased production to ship elsewhere. Miller says that vaccines are considered biologicals and are often difficult to manufacture and that these copies of the COVID-19 vaccines are “biosimiliars,” which follow different rules and guidelines including clinical trials and testing. Miller explains that many of these companies don’t have the time, infrastructure, or personal in place to run these trials.

Share
Read More
Share